ANTI-MYOSTATIN

Clinical trials for ANTI-MYOSTATIN explained in plain language.

Never miss a new study

Get alerted when new ANTI-MYOSTATIN trials appear

Sign up with your email to follow new studies for ANTI-MYOSTATIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New drug shows promise for muscle strength in SMA patients on standard therapy

Disease control Completed

This study tested a drug called apitegromab in 188 people aged 2 to 21 with later-onset spinal muscular atrophy (SMA types 2 and 3) who were already taking nusinersen or risdiplam. The goal was to see if adding apitegromab could improve muscle function more than a placebo. Partic…

Matched conditions: ANTI-MYOSTATIN

Phase: PHASE3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control

Last updated May 14, 2026 12:05 UTC

ANTI-MYOSTATIN

Get alerted when new ANTI-MYOSTATIN trials appear

New drug shows promise for muscle strength in SMA patients on standard therapy